A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis

Archives of Neurology

Volumn 66, Issue 5, 2009, Pages 587-592

  Rovira, Àlex ^a,h   Swanton, Josephine ^b   Tintoré, Mar ^a   Huerga, Elena ^a   Barkhof, Fredrick ^d   Filippi, Massimo ^e   Frederiksen, Jette L ^g   Langkilde, Annika ^g   Miszkiel, Katherine ^c   Polman, Chris ^d   Rovaris, Marco ^f   Sastre Garriga, Jaume ^a   Miller, David ^b   Montalban, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^g GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY;

ADULT; CENTRAL NERVOUS SYSTEM; COHORT STUDIES; CONTRAST MEDIA; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 66249087241     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.49     Document Type: Article

References (25)

1. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121-127. (Pubitemid 32591472)
2. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol. 2005;58(6):840-846.
3. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997;120(pt 11):2059-2069. (Pubitemid 27493740)
4. Tintoré M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol. 2000;21(4):702-706. (Pubitemid 30210434)
5. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2006;77(7):830-833. (Pubitemid 44023177)
6. Swanton JK, Rovira A, Tintoré M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007;6(8):677-686. (Pubitemid 47064439)
7. Tur C, Tintoré M, Rovira A, et al. Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler. 2008;14(5):631-635.
8. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227-231. (Pubitemid 13158528)
9. Frohman EM, Goodin DS, Calabresi PA, et al; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;61(5):602-611.
10. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 1988;38(12):1822-1825. (Pubitemid 19004571)
11. Bot JC, Barkhof F, Lycklama à Nijeholt G, et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology. 2002;223(1):46-56. (Pubitemid 34258189)
12. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med. 2002;346(3):158-164. (Pubitemid 34438881)
13. Beck RW, Trobe JD, Moke PS, et al; Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol. 2003;121(7):944-949. (Pubitemid 36841781)
14. Tintoré M, Rovira A, Río J, et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology. 2006;67(6):968-972. (Pubitemid 44454586)
15. Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol. 2004;61(2):217-221. (Pubitemid 38197554)
16. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008;131(pt 3):808-817.
17. O'Riordan JI, Gomez-Anson B, Moseley IF, Miller DH. Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci. 1999;167(2):132-136. (Pubitemid 29393102)
18. Van Der Knaap MS, Valk J. Acute disseminated encephalomyelitis and acute hemorrhagic encephalomyelitis. In: Van Der Knaap MS, Valk J, eds. Magnetic Resonance of Myelin, Myelination and Myelin Disorders. Heidelberg, Germany: Springer-Verlag; 1995:320-326.
19. Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(16)(suppl 2):S7-S12. (Pubitemid 46626001)
20. Heun R, Kappos L, Bittkau S, Staedt D, Rohrbach E, Schuknecht B. Magnetic resonance imaging and early diagnosis of multiple sclerosis. Lancet. 1988;2(8621):1202-1203. (Pubitemid 18267042)
21. Tas MW, Barkhol F, van Walderveen MA, Polman CH, Hommes OR, Valk J. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol. 1995;16(2):259-264.
22. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988;38(2):180-185. (Pubitemid 18036832)
23. McFarland HF, Stone LA, Calabresi PA, Maloni H, Bash CN, Frank JA. MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies. Mult Scler. 1996;2(4):198-205. (Pubitemid 126701266)
24. Kupersmith MJ, Alban T, Zeiffer B, Lefton D. Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain. 2002;125(pt 4):812-822. (Pubitemid 34279776)
25. Barkhof F, Hommes OR, Scheltens P, Valk J. Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology. 1991;41(8):1219-1222.